Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06794515

cGMP: Metabolism and Appetite Modulation

Metabolic Effects of cGMP: From Amino Acid Absorption Kinetics to Appetite Modulation

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Universidade Nova de Lisboa · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Phenylketonuria is an inborn error of phenylalanine metabolism. Although the phenylalanine-restricted diet is recognized as the mainstay of therapy, little is known about the impact of protein substitutes on the metabolism of patients with phenylketonuria. Therefore, the aim of this project is to study the impact of acute ingestion of casein glycomacropeptide supplemented with amino acids (cCGMP-AAs) alone or in combination with two different meals on amino acid absorption kinetics, glycaemic and insulinemic response, and on acute markers of appetite control. The main findings of this project will bring new insights into the dietary management of these patients, which may lead to improvements in protein substitutes formulations.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcGMP-AAs alone (20 g of protein equivalent)cGMP-AAs alone (20 g of protein equivalent)
DIETARY_SUPPLEMENTcGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled applecGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
DIETARY_SUPPLEMENTcGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oilcGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil

Timeline

Start date
2025-02-03
Primary completion
2025-03-28
Completion
2025-04-24
First posted
2025-01-27
Last updated
2025-01-27

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT06794515. Inclusion in this directory is not an endorsement.